Keith A Johnson

发表

Linear regression with a randomly censored covariate: application to an Alzheimer's study

Rebecca A Betensky, Keith A. Johnson, Folefac D Atem, 2017, Journal of the Royal Statistical Society. Series C, Applied statistics.

Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group

Chengjie Xiong, Nick C Fox, Eric M Reiman, 2016, PloS one.

Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression.

Keith A. Johnson, Elizabeth C Mormino, Willem Huijbers, 2015, Brain : a journal of neurology.

Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study

George Jewell, Eric M Reiman, Ranjan Duara, 2014, Molecular Psychiatry.

In vivo characterization of the early states of the amyloid-beta network.

Alex Becker, Jorge Sepulcre, Keith A. Johnson, 2013, Brain : a journal of neurology.

MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease.

Keith A. Johnson, Georges El Fakhri, Marie Foley Kijewski, 2003, Archives of neurology.

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans

Norbert Schuff, Adrian Preda, John Kornak, 2012, Proceedings of the National Academy of Sciences.

Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects

Keith A. Johnson, Georges El Fakhri, Nevena Zubcevik, 2017, The Journal of Nuclear Medicine.

Neurogenetic contributions to amyloid beta and tau spreading in the human cortex

Quanzheng Li, Jorge Sepulcre, Keith A. Johnson, 2018, Nature Medicine.

Imaging markers for Alzheimer disease

Martina Bocchetta, Clifford R Jack, Frederik Barkhof, 2013, Neurology.

Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease

Rebecca A Betensky, Keith A. Johnson, Elizabeth C Mormino, 2014, Neurology.

Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy.

Alexander Leemans, Panagiotis Fotiadis, Keith A. Johnson, 2015, Brain : a journal of neurology.

The ups and downs of the posteromedial cortex: age- and amyloid-related functional alterations of the encoding/retrieval flip in cognitively normal older adults.

Keith A. Johnson, Trey Hedden, Willem Huijbers, 2013, Cerebral cortex.

White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer’s disease

Michael Weiner, Clifford R Jack, Nick C Fox, 2018, PloS one.

Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly

Keith A. Johnson, Keith A Johnson, Julien Dumurgier, 2016, Neurology.

Amyloid Deposition Is Linked to Aberrant Entorhinal Activity among Cognitively Normal Older Adults

Keith A. Johnson, Elizabeth C Mormino, Trey Hedden, 2014, The Journal of Neuroscience.

Amyloid imaging of alzheimer’s disease using pittsburgh compound B

Keith A. Johnson, Keith A Johnson, 2006, Current Neurology and Neuroscience Reports.

Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum.

Keith A. Johnson, Keith A Johnson, R. Sperling, 2014, Journal of Alzheimer's disease : JAD.

PET imaging of tau protein targets: a methodology perspective

Cristina Lois, Julie C Price, Keith A Johnson, 2018, Brain Imaging and Behavior.

Network assemblies in the functional brain.

Jorge Sepulcre, Keith A. Johnson, Mert R Sabuncu, 2012, Current opinion in neurology.

Pathological correlations of [F‐18]‐AV‐1451 imaging in non‐alzheimer tauopathies

Keith A. Johnson, Matthew P Frosch, Derek H. Oakley, 2017, Annals of neurology.

A concise radiosynthesis of the tau radiopharmaceutical, [(18) F]T807.

Keith A. Johnson, Neil Vasdev, Thomas J Brady, 2013, Journal of labelled compounds & radiopharmaceuticals.

Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.

Kewei Chen, Eric M Reiman, Napatkamon Ayutyanont, 2011, Archives of neurology.

Dopamine transporter availability in clinically normal aging is associated with individual differences in white matter integrity

Keith A. Johnson, Anna Rieckmann, Randy L Buckner, 2016, Human brain mapping.

Quantitative SPECT leads to improved performance in discrimination tasks related to prodromal Alzheimer's disease.

Keith A. Johnson, Georges El Fakhri, Marie Foley Kijewski, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Structural tract alterations predict down-stream tau accumulation in amyloid positive older individuals

Jorge Sepulcre, Keith A. Johnson, Trey Hedden, 2018, Nature Neuroscience.

Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study

Panagiotis Fotiadis, Jeroen van der Grond, Keith A. Johnson, 2016, The Lancet Neurology.